TNFAIP8L1 (TNF Alpha Induced Protein 8 Like 1), also known as TIPE2 (TNFAIP8-like-2), is a member of the TNFAIP8 family of proteins that play important roles in cell death regulation, inflammatory responses, and cellular homeostasis [1]. Discovered as a homolog of TNFAIP8, this protein has emerged as a significant regulator of immune responses and cell survival pathways.
The TNFAIP8L1 gene encodes a 199-amino acid protein that shares significant homology with TNFAIP8. Like its family member, TNFAIP8L1 localizes primarily to the cytoplasm, where it interacts with various signaling molecules to modulate cellular processes [2]. The protein is expressed in various tissues, with particularly high expression in immune cells and neurons.
Located on chromosome 1p35.2, the TNFAIP8L1 gene is evolutionarily conserved, reflecting its important biological functions [3]. In the central nervous system, TNFAIP8L1 is expressed in neurons, astrocytes, and microglia, where it contributes to neuroprotection and modulates inflammatory responses.
| TNF Alpha Induced Protein 8 Like 1 | |
|---|---|
| Gene Symbol | TNFAIP8L1 |
| Full Name | TNF alpha induced protein 8 like 1 |
| Chromosome | 1p35.2 |
| NCBI Gene ID | [127700](https://www.ncbi.nlm.nih.gov/gene/127700) |
| OMIM | 612569 |
| Ensembl ID | ENSG00000134852 |
| UniProt ID | [Q8WXD0](https://www.uniprot.org/uniprot/Q8WXD0) |
| Protein Class | Immune regulator, Cell death regulator |
| Aliases | TIPE2, TNFAIP8L1 |
| Associated Diseases | Cancer, Parkinson's Disease, Neuroinflammation, Autoimmune disorders |
The TNFAIP8L1 gene spans approximately 4 kb on chromosome 1p35.2 and consists of 4 exons [4]. The gene promoter contains multiple regulatory elements, including:
TNFAIP8L1 possesses a domain structure similar to TNFAIP8:
N-terminus (1-65 aa) Middle (66-135 aa) C-terminus (136-199 aa)
┌────────────────────┐ ┌──────────────────┐ ┌────────────────────┐
│ DED-like domain │ │ Signaling │ │ DED-like domain │
│ (Death effector │ │ interaction │ │ (Death effector │
│ domain) │ │ region │ │ domain) │
│ │ │ │ │ │
│ Protein-protein │ │ Regulatory │ │ Cell death │
│ interactions │ │ phosphorylation │ │ modulation │
└────────────────────┘ └──────────────────┘ └────────────────────┘
Death Effector Domain (DED)-like — The N-terminal DED-like domain (amino acids 1-65) enables interactions with components of the apoptosis signaling machinery, similar to TNFAIP8 [5].
Central Signaling Region — The middle region (amino acids 66-135) mediates protein-protein interactions and contains regulatory phosphorylation sites.
C-terminal DED-like Domain — The C-terminal region (amino acids 136-199) contributes to apoptosis regulation and protein localization.
TNFAIP8L1 undergoes specific post-translational modifications [6]:
TNFAIP8L1/TIPE2 functions as a critical regulator of immune responses [7]:
This immune regulatory function makes TNFAIP8L1 essential for maintaining immune homeostasis.
TNFAIP8L1 modulates programmed cell death through multiple mechanisms [8]:
The duality of TNFAIP8L1's apoptosis regulation allows fine-tuning of cell death decisions.
TNFAIP8L1 regulates autophagy, an essential cellular quality control process [9]:
This function connects TNFAIP8L1 to cellular homeostasis and stress responses.
TNFAIP8L1 modulates NF-κB signaling through multiple pathways [10]:
This regulatory function links TNFAIP8L1 to inflammatory responses and immune regulation.
TNFAIP8L1 exhibits broad but regulated expression [11]:
| Tissue | Expression Level | Notes |
|---|---|---|
| Brain | Moderate | Neurons and glia |
| Spleen | Very high | Immune cells |
| Lymph nodes | High | Immune tissue |
| Lung | Moderate | Epithelial cells |
| Liver | Low-Moderate | Hepatocytes |
| Kidney | Moderate | Tubular cells |
Within the central nervous system [12]:
TNFAIP8L1 expression is controlled at multiple levels [13]:
TNFAIP8L1 plays protective roles in dopaminergic neuron survival [14]:
Neuroprotection:
Therapeutic Implications:
In neuroinflammatory conditions [15]:
In brain tumors [16]:
Emerging evidence links TNFAIP8L1 to AD [17]:
TNFAIP8L1 interacts with multiple protein partners [18]:
Direct Partners:
Functional Partners:
TNFAIP8L1 interfaces with multiple signaling cascades [19]:
Tnfaip8l1-deficient mice have provided important insights [20]:
Overexpression studies show [21]:
TNFAIP8L1 administration studies demonstrate [22]:
TNFAIP8L1 genetic variants have been associated with [23]:
| Variant Type | Effect | Disease Association |
|---|---|---|
| Missense | Altered function | Variable |
| Promoter variants | Altered expression | Modified risk |
| 3' UTR variants | Altered mRNA stability | Disease association |
Several approaches to modulate TNFAIP8L1 for therapeutic benefit are under investigation [24]:
| Approach | Mechanism | Status |
|---|---|---|
| Gene therapy | Deliver TNFAIP8L1 to CNS | Early research |
| Small molecules | Enhance expression | Discovery |
| Protein delivery | Recombinant protein | Early research |
| RNA modulation | Increase expression | Early research |
Therapeutic targeting of TNFAIP8L1 faces significant challenges [25]:
TNFAIP8L1 as a therapeutic target [26]:
| Feature | TNFAIP8L1 (TIPE2) | TNFAIP8 (SCC-S2) | TNFAIP3 (A20) |
|---|---|---|---|
| Function | Immune regulation | Apoptosis regulator | DUB + E3 ligase |
| Localization | Cytoplasmic | Cytoplasmic | Cytoplasmic |
| Primary role | Immune homeostasis | Cell death | Inflammation |
| Expression | High in immune cells | Broad | Inducible |
TNFAIP8L1 expression analysis may be useful for [27]:
No current clinical trials specifically targeting TNFAIP8L1, but:
TNFAIP8L1/TIPE2 represents an important regulator of immune responses and cell death with significant roles in both immune homeostasis and neuroprotection. Its functions in modulating inflammation and apoptosis make it relevant to neurodegenerative diseases, cancer, and autoimmune disorders. Understanding TNFAIP8L1's complex biology offers opportunities for therapeutic intervention in multiple disease contexts.